SCB will host a workshop to advance process, measurement, and analytical techniques of regenerative medicine products and services on May 15th and attend the World Advanced Therapies & Regenerative Medicine Congress.
Webinar: Using Patient Outcomes Data to Inform and Advance the Development of Emerging Cell and Gene Therapies
SCB’s Senior Technical Program Manager, Dawn Henke, will participate in a panel in this webinar through Cell & Gene Therapy Insights and sponsored by Be The Match BioTherapeutics. The webinar will focus on highlighting the impact outcomes data tracking has on ensuring innovative therapies are safe and effective, while also proving the retrospective data to expedite approvals and delivery.
On Friday, May 3, 2019, NIST will host and convene a one-day public workshop with stakeholders across industry, academia, non-profit, and government to discuss industry-wide measurement challenges and potential standards solutions for genome editing technologies, particularly for the development of human therapeutic products.
UMN 2019 Manufacturing Needs for Biofabrication of Engineered Tissues and Organs: Raw Materials and Supply Chain Challenges
Breakthroughs in cell technologies, materials science, and biofabrication methods, particularly 3D bioprinting, have laid a foundation for large-scale manufacturing of tissues and tissue-related products. Attendees of this conference will learn from industry and academic experts on what will be needed to bring biofabrication from its current prototype stage to reproducible, manufactured tissue products in the future.
The 9th International Conference and Exhibition on Advanced Cell and Gene Therapy (CELL THERAPY 2019) follows the theme “Novel innovations and breakthroughs in cell and gene therapy” and will be held on March 21-22, 2019 in Rome, Italy.
This webinar, sponsored by Brooks Life Sciences, brings together speakers who will discuss the governance of biosample collections, standardization efforts and quality control harmonization for biosamples as well as global best practices for the regulatory oversight of national and commercial biobank resources.
Join FACT on January 30th for a webinar where presenters will discuss FACT requirements for exceptional release of commercial cellular therapy products and then share their centers’ processes for release of nonconforming cellular therapy products in the U.S.